Page last updated: 2024-09-03

vadimezan and EHS Tumor

vadimezan has been researched along with EHS Tumor in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbera, M; Brindle, KM; Caputo, A; Carrara, M; Gobbi, S; Hu, DE; Kettunen, MI1
De Witte, PA; Ni, Y; Van de Putte, M1
Horsman, MR; Murata, R; Overgaard, J; Siemann, DW1
Lepler, S; Mercer, E; Rojiani, AM; Siemann, DW1

Other Studies

4 other study(ies) available for vadimezan and EHS Tumor

ArticleYear
Immune-modulating and anti-vascular activities of two xanthenone acetic acid analogues: A comparative study to DMXAA.
    International journal of oncology, 2009, Volume: 34, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Female; Flow Cytometry; Humans; I-kappa B Kinase; Immunity, Cellular; Leukemia; Magnetic Resonance Imaging; Mice; Mice, Inbred CBA; Microcirculation; NF-kappa B; Ovarian Neoplasms; Phosphorylation; Sarcoma, Experimental; Tumor Necrosis Factor-alpha; Umbilical Veins; Xanthones

2009
Exploration of the mechanism underlying the tumor necrosis avidity of hypericin.
    Oncology reports, 2008, Volume: 19, Issue:4

    Topics: Animals; Anthracenes; Carbocyanines; Female; Fibrosarcoma; Lipoproteins; Mice; Mice, Inbred C3H; Necrosis; Perylene; Sarcoma, Experimental; Xanthones

2008
Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid.
    Radiation research, 2001, Volume: 156, Issue:5 Pt 1

    Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Sarcoma, Experimental; Xanthenes; Xanthones

2001
Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy.
    International journal of cancer, 2002, May-01, Volume: 99, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Vessels; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Mice; Mice, Inbred C3H; Mice, Nude; Necrosis; Neovascularization, Pathologic; Sarcoma, Experimental; Stilbenes; Tumor Cells, Cultured; Xanthenes; Xanthones

2002